Article List

WPRIM Management System> DCMS> Cancer Research and Treatment> 2004> 36> 2

1. Isolated Diaphragmatic Metastasis Originated from Adenocarcinoma of the Colon.	Page:157—159
2. Site-Specific Mutagenesis in Human Cells by Bulky Exocyclic Amino-Substituted Guanine and Adenine Derivatives.	Page:151—156
3. The Expression of c-myc, bcl-2 and p53 Proteins in Adenocarcinomas of Lung.	Page:146—150
4. Synthetic CDCA Derivatives-Induced Apoptosis of Stomach Cancer Cell Line SNU-1 Cells.	Page:132—139
5. Radiofrequency Ablation for Metastatic Hepatic Tumor in Colorectal Carcinoma.	Page:128—131
6. Oxaliplatin with Biweekly, Low Dose Leucovorin and Bolus and Continuous Infusion 5-fluorouracil (Modified FOLFOX 4) as First-line Therapy for Patients with Metastatic Colorectal Cancer.	Page:115—120
7. 2002 Annual Report of the Korea Central Cancer Registry: Based on Registered Data from 139 Hospitals.	Page:103—114
8. Prospect of Anticancer Therapy.	Page:100—102
9. Randomized Phase III Trial of Cisplatin, Epirubicin, Leucovorin, 5-Fluorouracil (PELF) Combination versus 5-fluorouracil Alone as Adjuvant Chemotherapy in Curative Resected Stage III Gastric Cancer.	Page:140—145
10. Impact of the New AJCC Staging System and Adjuvant Treatment in Rectal Cancer.	Page:121—127
11. Molecular Epidemiology of Colon Cancer.	Page:93—99
12. Oxaliplatin: Is It a New Standard Weapon for Colorectal Cancer?.	Page:91—92